Strategic Advisor to ARC

Head of Department for Organ Donation, Oslo University Hospital 

Head of Department of Anesthesia and Intensive Care and Vice Scientific Director for Clinical Research

Executive Chairman of Migdal Holding, Insurance and Finance

Head of Group Value Based Healthcare & Lean, Humanitas 

Dr Nadine Hachach-Haram FRCS (Plast), BEM, is CEO and Founder of Proximie, Consultant Plastic Surgeon and Director of Clinical Innovation & Strategic Partnerships at Guy’s & St Thomas’ NHS Foundation Trust in London, UK. Growing up in post-war Lebanon was a formative experience, shaping her future career not just as a surgeon, but as an entrepreneur. Her initial motivation to help people grew into a wider goal to help bring safe surgery to the world. She created Proximie – a software platform that captures data and generates new insights to improve patient outcomes and OR productivity.

Dr. Klasko is an author, an entrepreneur and a believer in the creative and optimistic transformation of healthcare and higher education. He has been a health system CEO, a university president, and a dean of two medical colleges. Currently he is pursuing his passion to bridge academic health centers with the emerging world of generative AI, digital medicine and innovation. As President of Thomas Jefferson University, he directed a merger between an almost two century old health science university and a nationally ranked university for design and architecture. That merger was heralded by the Chronicle of Higher Education as one of the “few successful mergers between academic entities.” As CEO of Jefferson Health, he presided over the growth of the system from $1.5 billion to $9 billion including the acquisition of Health Partners Plan, making Jefferson the first integrated delivery and financial system in Philadelphia history and the largest health system in Philadelphia. This included a first of its kind digital “health at any address” partnership between Jefferson and leading health venture capital firms such as General Catalyst, a16z and Oak HC. He has been a board member and advisor to several AI behavioral health entities and led the Forbes Health Summit this year on the ethical and regulatory “unintended consequences” of generative AI. His most recent book, Feelin’ Alright: How the Message in the Music Can Make Healthcare Healthier uses music and creativity to tackle the biggest issues in healthcare His fifth book (with Hemant Taneja of General Catalyst) in 2021, UnHealthcare: A Manifesto for Health Assurance has become the manual for both founders and health system CEOs for merging the venture capital world with the traditional healthcare ecosystem. Dr. Klasko serves as Executive in Residence at General Catalyst, North American ambassador for Sheba Medical Center in Israel, and as CMO and Operating Partner of Abundant Partners. He is the lead independent director for Teleflex (TFX:NYSE), a multi-billion dollar medical device company. In 2022, President Biden appointed him to the National Board of Education Sciences. He serves as a member of the Founders Circle for BrightEdge, a unique impact investing arm of the American Cancer Society. Dr. Klasko is also the board chair of Opera Philadelphia and a trustee of Rosalind Franklin University and Chicago Medical School. Over the past five years he has been awarded by Fast Company as one of the “top 25 most creative people in business,” by Modern Healthcare as the “#2 most influential person in healthcare” and by Ernst and Young as the “entrepreneur of the year.” He lives in Miami and New York with his wife Colleen Wyse, a commercial model and former fashion executive with senior positions in Vogue, W and Glamour.

Chief Executive Officer of the Charitè – Universitätsmedizin Berlin

Director of the Center for Precision Medicine at Sahlgrenska University Hospital

CEO at Rigshospitalet in Copenhagen

Chief Executive Officer, University College London Hospitals

Chief Executive Officer of the Humanitas Group

Director Acute Clinic, Oslo University Hospital  

Dr. Avi Tsur, MD, MBA is Director of Obstetrics and Gynecology at Sheba Beyond, Chief Medical Director of ARC, and Founder of the Sheba ARC Women’s Health Innovation Center, advancing women’s healthcare through AI, telemedicine, and precision health. He received his medical and clinical training at Hadassah Medical School, Sheba Medical Center, and Stanford University, and holds an MBA in Healthcare Innovation from Reichman University. An internationally recognized leader in maternal–fetal telemedicine, Dr. Tsur has authored over 70 scientific publications and eight book chapters. He is the primary medical inventor of the Lioness device for preventing spontaneous preterm birth and co-founder of Shela Health, pioneering maternal–fetal precision medicine.

Chief Transformation Officer and Chief Innovation Officer, Sheba Medical Center, Director and Founder, ARC Innovation, Israel